24.12.2018 Views

FM OCTOBER 2018 ISSUE - digital edition

You also want an ePaper? Increase the reach of your titles

YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.

in Lucknow, All India Institute of Medical<br />

Sciences in Delhi, Postgraduate Institute<br />

in Chandigarh, Manipal University in<br />

Mangalore). The total medical geneticists<br />

in the country may be about 100, which<br />

is totally inadequate for a country the<br />

size of India.<br />

Similarly, these tests only measure the probability<br />

for a limited number of conditions, while amniocentesis<br />

and CVS can be used to test for a much broader number<br />

of genetic abnormalities, emphasises Nateram, which<br />

makes SNP-based Panorama NIPT.<br />

Clearly, the technical ability to test for a condition<br />

does not necessarily correspond with a clinical benefit.<br />

Hence it is important for the companies to be certain<br />

about the benefit of every new addition.<br />

“Test results must aid clinical decision-making and<br />

should be beneficial to patients. Each condition added to<br />

a screening panel adds to the overall false positive rate<br />

of the test and decreases the positive predictive value,’’<br />

says Dr Schmid of Roche Sequencing Solutions, which<br />

recently included 22q11.2 microdeletion testing as part<br />

of its prenatal test portfolio. Therefore, additional cfDNA<br />

test menu options must focus on clinically relevant<br />

conditions and require comprehensive validation studies<br />

to demonstrate clinical utility in the population to be<br />

tested.<br />

Furthermore, counselling becomes more challenging<br />

with an increase in the complexity of testing options and<br />

the potential of identifying conditions with an uncertain<br />

prognosis, according to Dr Schmid.<br />

Test results<br />

must aid clinical<br />

decision-making<br />

and should be<br />

beneficial to<br />

patients. Each<br />

condition added<br />

to a screening<br />

panel adds to<br />

the overall false<br />

positive rate<br />

of the test and<br />

decreases the<br />

positive predictive<br />

value.<br />

Maximilian<br />

Schmid M.D.<br />

Head of Medical<br />

Affairs, Roche<br />

Sequencing Solutions,<br />

California<br />

HEARING LOSS<br />

MEDGONOME OFFERS<br />

GENETIC TESTING<br />

FOR COUPLES<br />

MedGenome Labs, a genomicsbased<br />

research and diagnostics<br />

company, offers genetic testing<br />

for couples with a family history of<br />

hearing loss.<br />

Awareness and early detection<br />

are the only ways to prevent<br />

genetic hearing loss disorders<br />

from being passed down to next<br />

generations.<br />

Couples should undergo<br />

pre-conception counselling with a<br />

genetic counsellor, especially when<br />

there is positive family history<br />

for a disorder. Such counselling<br />

sessions help the couple better<br />

understand the risk to the child as<br />

well as help recommend a suitable<br />

prenatal genetic test, according<br />

to Dr Sunitha Tella, head, Clinical<br />

Genetics and Fetal Medicine<br />

Department, Institute of Genetics<br />

and Hospital for Genetic Diseases,<br />

Hyderabad.<br />

“In one such case, the<br />

first born child had cognitive<br />

disorders. It was recommended,<br />

to understand if the hearing<br />

impairment was due to genetic<br />

factors basis, which appropriate<br />

screening measures could be<br />

taken when they plan a second<br />

child,” she said. Dr Tella suggested<br />

the family to undergo genetic<br />

testing at MedGenome Labs,<br />

Bengaluru.<br />

The blood samples of the<br />

parents and their first child<br />

revealed their first born had two<br />

mutations or variants in the GJB2<br />

gene, which is associated with<br />

hearing loss, while the parents<br />

were found to be carrying one<br />

mutation each, making them<br />

‘carriers’ of the disease. This meant<br />

that their child may have 25 per<br />

cent chance of being affected with<br />

hearing impairment.<br />

The foetus was tested<br />

for these two variants and<br />

was found that it was only<br />

harbouring one of the two<br />

mutations found in the first<br />

child. In this case the child<br />

would be a carrier of the<br />

disease and wouldn’t suffer<br />

from hearing loss, she added.<br />

<strong>2018</strong> / FUTURE MEDICINE / 25

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!